Krakatoa’s point of use media manufacturing reduces greenhouse gas emissions by 65% per unit of media produced. San Diego, CA – Nucleus Biologics, The Cell Performance Company™, is proud to announce the launch of Krakatoa™, an innovative, first-to-market media maker that will allow researchers to manufacture cell culture media at point of use. Moving media […]
MADISON, Wis. — Mirus Bio LLC, a leading provider of delivery solutions within Gamma Biosciences, today launched TransIT-VirusGEN® SELECT Transfection Kits for large-scale viral vector production for cell and gene therapy applications. The kits support pre-clinical and process development activities and consist of the TransIT-VirusGEN Transfection Reagent, complex formation solution and enhancer. The full kits are designed to improve the […]
Strategic investment and partnership brings Spatial’s multiomics platform and seqFISH technology to Fulgent’s comprehensive suite of genomic testing solutions TEMPLE CITY, Calif. & PASADENA, Calif. — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today […]
Company Shows Another Year of Record Growth and Advancements STATE COLLEGE, Pa. — INDIGO Biosciences, Inc. (INDIGO), the recognized industry leader in nuclear receptor and in vitro toxicology testing solutions, has announced a record earnings year for 2021. INDIGO showed more than a 17% percent increase in revenue vs its previous record in 2019. “INDIGO provides […]
New facility supports University of Montreal researchers with advanced imaging tools WALTHAM, Mass. — Olympus continues to demonstrate its commitment to advancing bioscience research with the opening of the new Olympus Discovery Center at the University of Montreal’s Centre interdisciplinaire de recherche sur le cerveau et l’apprentissage (Center for Interdisciplinary Research on Brain and Learning, […]
We are glad to announce that we have reached a settlement with Organovo in which we agreed to resolve all aspects of the disputes between the parties. Organovo and BICO were engaged in several legal disputes regarding Organovo’s patents. Under the new agreement, all civil actions regarding potential infringements and IPRs concerning validity of Organovo’s patents are […]
Fully automated GeoMx RNA workflow reduces hands-on time, allowing users to prepare up to 30 slides in one day with high reproducibility SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of a fully automated GeoMx® RNA protocol on BOND RX […]
Funding will support recruitment, commercial partnerships, and further development of Semarion’s SemaCyte cell assaying platform, which turns adherent cells into liquid reagents to enable novel drug screening methodologies Investors include Parkwalk Advisors, University of Cambridge Seed Funds, Martlet Capital, and angel investors Cambridge, UK: Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory […]
LIMERICK, PA Rockland Immunochemicals, Inc. (Rockland), a leading life science reagents manufacturer and service provider with years of expertise in antibodies, assay, and reagent development for early- to late-stage bioprocessing and the Jefferson Institute for Bioprocessing (JIB), a full-service development and training organization specializing in biologics and biopharmaceuticals announced today that an agreement has been signed […]
New technology reveals include first data from upcoming Xenium In Situ Analysis Platform PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today unveiled new details about upcoming products and capabilities across its single cell, spatial, and in situ platforms at its second annual […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
